A novel NAPP risk model was firstly constructed and demonstrated to achieve accurate risk stratification for TCL patients with PE. PERGs, especially HIF1A, were closely related to tumor immune, and could act as molecular predictors for prognosis in TCL patients. These findings have the promising potential to facilitate the identification of high-risk population and the establishment of individualized treatment in TCL patients with PE.
12 months ago
Pleural effusion
|
HIF1A (Hypoxia inducible factor 1, alpha subunit) • COL1A1 (Collagen Type I Alpha 1 Chain)